-+ 0.00%
-+ 0.00%
-+ 0.00%

SYNACT PHARMA AB - FDA DISCUSSIONS ON TRIAL DESIGN PLANNED FOR Q4 2026

Reuters·09/07/2026 09:03:43

Please log in to view news